SIBN delivered a strong EPS beat and raised guidance, reinforcing its growth trajectory. Watch for the 510(k) clearance of the third breakthrough device in Q4 and the October CMS MS-DRG change, which could expand adoption. The stock may react positively in the near term given the beat and improved profitability.
Price Chart
Executive Summary
SI-BONE reported Q2 2026 revenue of $56.0M (up 15.2% YoY, 1.1% above consensus) and EPS of -$0.09 (40% beat vs -$0.15 consensus). The company raised FY revenue guidance to $231-233M (~15-16% growth), posted positive adjusted EBITDA of $2.8M, and highlighted 19% growth in active U.S. physicians. Results show accelerating commercial execution and profitability despite remaining GAAP-unprofitable.
Key Financial Metrics
Key Facts
- Worldwide revenue $56.0M, +15.2% YoY
- EPS -$0.09 vs consensus -$0.15 (40% beat)
- FY 2026 revenue guidance raised to $231-233M (prior $230-233M)
- Positive adjusted EBITDA of $2.8M vs $1.0M a year ago (+178%)
- Active U.S. physician base grew 19% to 1,715
- Submitted 510(k) for third breakthrough device; CMS finalized favorable MS-DRG reclassification for iFuse Bedrock Granite effective October 1
Financial Impact
Revenue beat of $0.6M (1.1% above consensus); EPS beat of $0.06 per share (40%); guidance low-end raised $1M
Risk Factors
- Still GAAP net loss of $4.1M in the quarter
- Guidance assumes continued procedure volume growth (14.9% in Q2)
- Reimbursement changes could affect adoption of new devices
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3337885 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | Press Release | $20.54 | awaiting T+20 | — | $21.31 (+3.75%) |
Oct 13, 2026 13d ago | 144 | $19.68 | awaiting T+20 | — | $21.31 (+8.28%) |
Aug 26, 2026 8w ago | Insider Cluster | $19.20 $18.52 | ▲ +3.54% | ▲ +3.03% | $21.31 (−10.99%) |
Aug 21, 2026 9w ago | Insider Cluster | $19.47 $18.81 | ▲ +3.39% | ▲ +4.70% | $21.31 (−9.45%) |
Aug 21, 2026 9w ago | 144 | $19.47 $18.81 | ▼ −3.39% | ▼ −4.70% | $21.31 (+9.45%) |
Aug 18, 2026 9w ago | Insider Cluster | $19.91 $18.04 | ▼ −9.39% | ▼ −7.44% | $21.31 (+7.03%) |
Aug 18, 2026 9w ago | Insider Cluster | $19.91 $18.04 | ▼ −9.39% | ▼ −7.44% | $21.31 (+7.03%) |
Aug 3, 2026 12w ago | Press Release | $18.44 $18.92 | ▲ +2.60% | ▲ +3.84% | $21.31 (+15.56%) |
Jun 8, 2026 20w ago | Insider Cluster | $15.53 $17.30 | ▲ +11.40% | ▲ +9.95% | $21.31 (+37.22%) |
Jun 8, 2026 20w ago | 8-K | $15.53 $17.30 | ▲ +11.40% | ▲ +9.95% | $21.31 (+37.22%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers